Dr. Aaron Phillips traces the translational journey of a discovery that began in a foundational laboratory and is now advancing through pivotal clinical trials aimed at stabilizing cardiovascular function.
The session includes a conversation with a research participant who received an implanted spinal cord stimulator as part of the trial, offering a rare first person perspective on living with this emerging therapy. Attendees will also see a live demonstration of hind limb negative pressure in a mouse model used to study cardiovascular instability, along with a short lecture outlining the scientific and clinical milestones that transformed a foundational discovery into a human therapy over the past eight years. The discussion highlights both the biological mechanisms and the strategic pathway required to move neuromodulation from bench science to clinical impact.
Featuring Insights from
Aaron Phillips
,
PhD
Dr. Aaron Phillips was trained in biosciences and mathematics. His appreciation of the elegant interactions between the nervous and cardiovascular systems, and how these interactions are disrupted in clinical conditions, has driven his research into the development of novel therapeutics for people with neurological health issues.
Sponsored by
ADInstruments
In Partnership with
American Physiological Society
Founded in 1887, the American Physiological Society is a global leader in expanding knowledge related to biological function. We connect a multidisciplinary community of nearly 10,000 scientists and educators from around the world, driving collaboration and spotlighting scientific discoveries in physiology and related disciplines. Our members are advancing treatments and cures for everything from cancer and heart disease, to obesity and addiction. They are also deepening our insight into living organisms generally, helping us to better understand how things like climate change are affecting the world around us.
